Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers

  • Noh, Joseph J.; 
  • Kim, Min Kyu; 
  • Choi, Min Chul; 
  • Lee, Jeong-Won; 
  • Park, Hyun; 
  • 외 4명
Citations

WEB OF SCIENCE

28
Citations

SCOPUS

31

초록

Purpose This study was to investigate the frequency of mismatch repair deficiency/high microsatellite instability (MMRd/MSI-H) in gynecologic malignancies and the efficacy of immune checkpoint inhibitors (ICIs) in patients with recurrent gynecologic cancers according to MMR/MSI status. Materials and Methods We conducted a multi-center retrospective review on the patients who were diagnosed with gynecologic cancers between 2015 and 2020. Their clinicopathologic information, results of immunohistochemistry staining for MLH1/MSH2/ MSH6/PMS2 and MSI analysis, tumor response to treatment with ICIs were investigated. Results Among 1,093 patients included in the analysis, MMRd/MSI-H was most frequent in endometrial/uterine cancers (34.8%, 164/471), followed by ovarian, tubal, and peritoneal cancers (12.8%, 54/422) and cervical cancer (11.3%, 21/186). When assessed by histology without regard for cancer types, the frequency of MMRd/MSI-H was 11.0% (38/345) in high-grade serous adenocarcinoma, 38.6% (117/303) in endometrioid adenocarcinoma, and 30.2% (16/53) in carcinosarcoma. A total of 114 patients were treated with ICIs at least once. The objective response rate (ORR) was 21.6% (8/37) in cervical cancer, 4.7% (2/43) in ovarian cancer, and 25.8% (8/31) in endometrial/uterine cancers. Univariate regression analysis identified MMRd/MSI-H as the only significant factor associated with the ORR (28.9% [11/38] vs. 11.8% [9/76]; odds ratio, 3.033; 95% confidence interval, 1.129 to 8.144; p=0.028). Conclusion The frequency of MMRd/MSI-H is moderate to high in gynecologic cancers in the Korean population. MMRd/MSI-H could be effective predictive biomarkers in gynecologic cancers of any type.

키워드

Gynecologic neoplasms; Immune checkpoint inhibitors; Microsatellite instability; Mismatch repair; Recurrence; ANTITUMOR-ACTIVITY; PD-L1 EXPRESSION; SAFETY; TUMORS; PEMBROLIZUMAB; NIVOLUMAB
제목
Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers
저자
Noh, Joseph J.; Kim, Min Kyu; Choi, Min Chul; Lee, Jeong-Won; Park, Hyun; Jung, Sang Geun; Joo, Won Duk; Song, Seung Hun; Lee, Chan
DOI
10.4143/crt.2021.828
발행일
2022-10
유형
Article
저널명
Cancer Research and Treatment
권
54
호
4
페이지
1200 ~ 1208